3 Growth Stocks Investors Can Get for Cheap (While the Sale Lasts)

These three growth stocks are enticing buys at these discounted prices.

| More on:

Last week, Statistics Canada reported that Canada’s GDP (gross domestic product) rose 1.7% in the first quarter, which was lower than analysts’ expectation of 2.2%. Besides, the weaker manufacturing data from the United States on Monday has also raised concerns about the global economy, thus weighing on the equity markets. The S&P/TSX Composite Index is down around 1.3% this month amid broader weakness. However, long-term investors should not worry about short-term volatility and go long on quality stocks. I am bullish on these three top growth stocks currently available at attractive levels.

Docebo

Docebo (TSX:DCBO), which offers corporate e-learning solutions, has been under pressure over the last few months, losing 35.5% of its stock value compared to its 52-week high. Although the company posted an impressive first-quarter performance, its 2024 guidance has made investors skeptical. Besides, investors are worried that the challenging macro environment could lower IT spending, thus impacting the company.

However, the correction offers an excellent buying opportunity for long-term investors, as Docebo’s addressable market is expanding. More companies are including e-learning modules in their strategies due to growth in remote working and their cost-effectiveness. Besides, Docebo is adding AI (Artificial Intelligence)-powered features to its platform, which could expand its customer base. Further, the company’s multi-year contacts with its clients and higher net dollar retention rate stabilize its financials. Considering its healthy long-term growth prospects and discounted stock price, I believe long-term investors should start accumulating Docebo at these levels.

goeasy

Second on my list would be goeasy (TSX:GSY), which offers leasing and lending services to subprime customers. Although the company’s stock price has increased by 18.2% this year, its valuation still looks attractive, with its NTM (next 12 months) price-to-earnings multiple at 10.4.

Besides, goeasy is expanding its loan portfolio, which has recently surpassed $4 billion. Its retail network of more than 400 locations, online lending platforms, and point-of-sale financing offered in several verticles, including retail, automotive, home improvement, and healthcare, have helped the company expand its loan portfolio. Meanwhile, the company’s management expects its loan portfolio to reach $5.8 to $6.2 billion by 2026, with the midpoint representing a 50% increase from its current levels. The expansion could boost its financials.

goeasy also rewards its shareholders with consistent dividend growth. Since 2014, the company has raised its dividends at an annualized rate of around 30%. Meanwhile, its forward yield stands at 2.5%.

BlackBerry

Another growth stock that is trading at a substantial discount is BlackBerry (TSX:BB), which has lost over 50% of its stock value compared to its 52-week high. Due to the lower-than-expected growth in its IoT (Internet of Things) sector, the company has been under pressure. Amid the steep correction, the company’s NTM price-to-sales multiple has declined to 2.7.

However, BlackBerry’s long-term growth prospects look healthy as demand for next-generation software-defined vehicles grows. Besides, its royalty backlog from new design wins, innovative product launches, and strategic partnerships could support its growth. Further, the company’s expanded product offerings and blue-chip customer base could help overcome the near-term weakness in the cybersecurity segment and drive its financials in the coming quarters. So, despite the near-term volatility, investors can buy the stock to earn multi-fold returns in the long run.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned. The Motley Fool recommends Docebo. The Motley Fool has a disclosure policy.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »